Skip to content

A Prospective, Multicenter, Randomized Controlled Trial on the Comparative Analysis of Short-term and Long-term Outcomes Between Modified Bacon Procedure and Immediate Coloanal Anastomosis with Protective Ileostomy for Low Rectal Cancer

A Prospective, Multicenter, Randomized Controlled Trial on the Comparative Analysis of Short-term and Long-term Outcomes Between Modified Bacon Procedure and Immediate Coloanal Anastomosis with Protective Ileostomy for Low Rectal Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122100
Enrollment
Unknown
Registered
2026-04-09
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low rectal cancer

Interventions

Intervention Group:Modified Bacon Procedure
Control Group:Immediate Coloanal Anastomosis with Protective Ileostomy

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 75 years; 2. Histopathologically confirmed high-grade or intermediate-grade adenocarcinoma, or preoperative colonoscopy suggesting malignant transformation of a villous adenoma; 3. The lower edge of the tumor is located =5 cm from the anal verge, and the primary tumor diameter is <5 cm; 4. Non-recurrent rectal cancer; 5. Absence of synchronous multiple colorectal cancers; 6. Patients may or may not have received neoadjuvant chemoradiotherapy; 7. Preoperative tumor staging is Stage I (cT1~2N0M0); For Stage II~III (cT3~4N0~2M0) patients, after neoadjuvant therapy, tumors above the levator hiatus must be downstaged to = ycT3N0-2M0, and tumors at or below the levator hiatus must be downstaged to = ycT2NxM0 (i.e., invasion depth does not exceed the internal sphincter); 8. Preoperative American Society of Anesthesiologists (ASA) physical status classification of I~III; 9. Absence of preoperative local complications (including intestinal obstruction, intestinal perforation, abdominal abscess formation, etc.); 10. Good preoperative anal control function (preoperative Wexner score = 5); 11. Preoperative assessment indicates the patient is physically capable of undergoing radical ultra-low anterior resection and is suitable for either immediate coloanal anastomosis with ileostomy or the modified Bacon procedure (comprehensive assessment including nutritional risk and comorbidities); 12. The patient and their family must understand and be willing to participate in this study and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients requiring emergency surgery due to intestinal obstruction, perforation, or hemorrhage; 2. Patients with tumor invasion of the external sphincter, levator ani muscle, or adjacent organs requiring combined organ resection; 3. Patients with pathological types of poorly differentiated or undifferentiated carcinoma, mucinous adenocarcinoma, or signet-ring cell carcinoma; 4. Patients with familial adenomatous polyposis, Lynch syndrome-associated rectal cancer, or active inflammatory bowel disease; 5. Patients with other concurrent malignancies; 6. Patients with distant metastasis; 7. Patients with a history of previous colorectal or anorectal surgery or disease; 8. Patients with poor preoperative anal function (preoperative Wexner score = 6); 9. Patients with preoperative digital rectal examination indicating anal stenosis that cannot be relieved; 10. Patients with preoperative ASA classification of IV or V; 11. Patients with severe hepatic, renal, cardiac, pulmonary, or coagulation dysfunction, or severe underlying diseases unable to tolerate surgery; 12. Pregnant and/or lactating patients; 13. Patients with abnormal cognitive status, illiteracy/difficulty reading and writing, or a history of severe mental illness; 14. Patients with uncontrolled preoperative infection; 15. Patients currently participating in other clinical trials; 16. Patients with any other clinical or laboratory findings deemed by the investigator as unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
Postoperative 30-day Overall Complication Rate;Postoperative 30-day Complication Profile and Severity;

Secondary

MeasureTime frame
Intraoperative Blood Loss;Operative Time;Distant Metastasis Rate;Local Recurrence Rate;Overall Survival Rate;Postoperative Hospital Stay;Fecal Incontinence Score;Long-term Complication Rate;Postoperative Pain Score;Quality of Life Core Questionnaire Score;Time to First Liquid Intake;Time to First Normal Diet;Time to First Flatus;Low Anterior Resection Syndrome Score;Time to First Ambulation;Disease-free Survival Rate;

Countries

China

Contacts

Public ContactJunhong Hu

The First Affiliated Hospital of Zhengzhou University

hjh-8282@163.com+86 183 3717 8698

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026